These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Resistance mutations in HIV-1 infected pregnant women and their infants receiving antiretrovirals to prevent HIV-1 vertical transmission in China. Han J, Wang L, Jiang Y, Zhang Q, Fang L, Yao J, Wang Q. Int J STD AIDS; 2009 Apr; 20(4):249-54. PubMed ID: 19304969 [Abstract] [Full Text] [Related]
4. Effective program against mother-to-child transmission of HIV at Saint Camille Medical Centre in Burkina Faso. Simpore J, Pietra V, Pignatelli S, Karou D, Nadembega WM, Ilboudo D, Ceccherini-Silberstein F, Ghilat-Avoid-Belem WN, Bellocchi MC, Saleri N, Sanou MJ, Ouedraogo CM, Nikiema JB, Colizzi V, Perno CP, Castelli F, Musumeci S. J Med Virol; 2007 Jul; 79(7):873-9. PubMed ID: 17516517 [Abstract] [Full Text] [Related]
6. Genotypic resistance tests for the management of the HIV-infected pregnant woman. Bassetti D, Cargnel A. Scand J Infect Dis Suppl; 2003 Jul; 106():70-4. PubMed ID: 15000589 [Abstract] [Full Text] [Related]
7. Nevirapine resistance after single dose prophylaxis. Eshleman SH, Jackson JB. AIDS Rev; 2002 Jul; 4(2):59-63. PubMed ID: 12152519 [Abstract] [Full Text] [Related]
8. Antiretroviral resistance patterns and HIV-1 subtype in mother-infant pairs after the administration of combination short-course zidovudine plus single-dose nevirapine for the prevention of mother-to-child transmission of HIV. Chalermchockcharoenkit A, Culnane M, Chotpitayasunondh T, Vanprapa N, Leelawiwat W, Mock PA, Asavapiriyanont S, Teeraratkul A, McConnell MS, McNicholl JM, Tappero JW. Clin Infect Dis; 2009 Jul 15; 49(2):299-305. PubMed ID: 19522656 [Abstract] [Full Text] [Related]
10. Zidovudine with nevirapine for the prevention of HIV mother-to-child transmission reduces nevirapine resistance in mothers from the Western Cape, South Africa. van Zyl GU, Claassen M, Engelbrecht S, Laten JD, Cotton MF, Theron GB, Preiser W. J Med Virol; 2008 Jun 15; 80(6):942-6. PubMed ID: 18428139 [Abstract] [Full Text] [Related]
11. Preventing mother-to-child transmission of HIV: successes and challenges. McIntyre J. BJOG; 2005 Sep 15; 112(9):1196-203. PubMed ID: 16101596 [Abstract] [Full Text] [Related]
12. Transmission of human immunodeficiency virus type 1 nevirapine resistance mutation K103N from a treatment-naive mother to her child. Schmitz T, Kleinkauf N, Klempa B, Ringe H, Varnholt V, Grosch-Wörner I. Pediatr Infect Dis J; 2006 Mar 15; 25(3):275-6. PubMed ID: 16511398 [Abstract] [Full Text] [Related]
13. Drug resistance among HIV-infected pregnant women receiving antiretrovirals for prophylaxis. Duran AS, Losso MH, Salomón H, Harris DR, Pampuro S, Soto-Ramirez LE, Duarte G, de Souza RS, Read JS, NISDI Perinatal Study Group. AIDS; 2007 Jan 11; 21(2):199-205. PubMed ID: 17197811 [Abstract] [Full Text] [Related]
18. Nevirapine plus zidovudine to prevent mother-to-child transmission of HIV. Herzmann C, Karcher H. N Engl J Med; 2004 Nov 04; 351(19):2013-5; author reply 2013-5. PubMed ID: 15525729 [No Abstract] [Full Text] [Related]
19. Evidence behind the WHO guidelines: hospital care for children: what antiretroviral agents and regimens are effective in the prevention of mother-to-child transmission of HIV? Nightingale S, Dabis F. J Trop Pediatr; 2006 Aug 04; 52(4):235-8. PubMed ID: 16877674 [No Abstract] [Full Text] [Related]